James Aronson

Sourced from institutional research profiles (UAMS TRI or ARA).

High Impact

Role not yet determined

UAMS primary UA Little Rock University of Central Arkansas

Also affiliated: Arkansas Children's Hospital (1985–2020); Amgen (United States) (2002–2005); Children's Mercy Hospital (1998); Duke University (1983); Chungnam National University (2003); University of Arkansas Medical Center (1988); Duke Medical Center (1983); John L. McClellan Memorial Veterans Hospital (1988); Arkansas Children's Research Institute (1996–2016); University of Nebraska Medical Center (1990)

34 h-index 82 pubs 4,116 cited

Research Areas

Biomedical Subjects

Links

Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

James Aronson's research has focused on the study of infectious diseases, with a particular emphasis on host-pathogen interactions. His work investigates the mechanisms by which microbes cause disease and the body's response to these infections. Aronson has explored various aspects of microbial pathogenesis and the development of strategies to combat infectious agents.

Metrics

h-index: 34
Publications: 82
Citations: 4,116

Selected Publications

Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V (2020)

Bone 10 citations DOI OpenAlex
Nutlin‐3 treatment spares cisplatin‐induced inhibition of bone healing while maintaining osteosarcoma toxicity (2016)

Journal of Orthopaedic Research® 8 citations DOI OpenAlex
Interobserver Variability Using a Commercially Available System of Archived Digital Radiography With Integrated Computer-assisted Measurements for Scoliosis Cobb Angles (2013)

Journal of Pediatric Orthopaedics 15 citations DOI OpenAlex
Cisplatin inhibits bone healing during distraction osteogenesis (2013)

Journal of Orthopaedic Research® 42 citations DOI OpenAlex
Metabolic Endotoxemia And Inhibition Of Direct Bone Regeneration: A Pilot Study (2012)

Zenodo (CERN European Organization for Nuclear Research) DOI OpenAlex
Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation (2012)

Calcified Tissue International 47 citations DOI OpenAlex
Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration (2012)

Bone 20 citations DOI OpenAlex
Inhibin A enhances bone formation during distraction osteogenesis (2011)

Journal of Orthopaedic Research® 24 citations DOI OpenAlex
Distraction osteogenesis in TNF receptor 1 deficient mice is protected from chronic ethanol exposure (2011)

Alcohol 8 citations DOI OpenAlex
Restoration of regenerative osteoblastogenesis in aged mice: Modulation of TNF (2009)

Journal of Bone and Mineral Research 56 citations DOI OpenAlex
Direct bone formation during distraction osteogenesis does not require TNFα receptors and elevated serum TNFα fails to inhibit bone formation in TNFR1 deficient mice (2009)

Bone 16 citations DOI OpenAlex
Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: Role of the TNF signaling axis (2007)

Toxicology and Applied Pharmacology 34 citations DOI OpenAlex
A novel rat model for the study of deficits in bone formation in type-2 diabetes (2007)

Acta Orthopaedica 48 citations DOI OpenAlex
A novel mouse model for the study of the inhibitory effects of chronic ethanol exposure on direct bone formation (2006)

Alcohol 24 citations DOI OpenAlex
Effects of Systemic and Local Administration of Recombinant Human IGF-I (rhIGF-I) on De Novo Bone Formation in an Aged Mouse Model (2006)

Journal of Bone and Mineral Research 73 citations DOI OpenAlex